Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A Mouse Model of Amyloid β Oligomers: Their Contribution to Synaptic Alteration, Abnormal Tau Phosphorylation, Glial Activation, and Neuronal Loss <i>In Vivo</i>

6 Apr 2010

Abstract excerpt

Although amyloid beta (Abeta) oligomers are presumed to cause synaptic and cognitive dysfunction in Alzheimer's disease (AD), their contribution to other pathological features of AD remains unclear. To address the latter, we generated APP transgenic mice expressing the E693Delta mutation, which causes AD by enhanced Abeta oligomerization without fibrillization. The mice displayed age-dependent accumulation of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alzheimer's disease research and treatments
Share to Neuroscience and Neuropharmacology Research
Share to Nuclear Receptors and Signaling

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 20371804
DOI: 10.1523/jneurosci.5825-09.2010

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 23 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A Mouse Model of Amyloid β Oligomers: Their Contribution to Synaptic Alteration, Abnormal Tau Phosphorylation, Glial Activation, and Neuronal Loss <i>In Vivo</i>PMID 20371804Read ↗

APPSW Transgenic Mice Develop Age-related Aβ Deposits and Neuropil Abnormalities, but no Neuronal Loss in CA1Semantic proximity Read ↗

Early intraneuronal accumulation and increased aggregation of phosphorylated Abeta in a mouse model of Alzheimer’s diseaseSemantic proximity Read ↗

Differential neural circuit vulnerability to β-amyloid and tau pathologies in novel Alzheimer’s disease miceSemantic proximity Read ↗

Effects of rising amyloidβ levels on hippocampal synaptic transmission, microglial response and cognition in <i>APP</i> <sub>Swe</sub> / <i>PSEN1</i> <sub>M146V</sub> transgenic miceSemantic proximity Read ↗

Regulatable transgenic mouse models of Alzheimer disease: onset, reversibility and spreading of Tau pathology.Semantic proximity Read ↗

Mouse Models of Alzheimer’s DiseaseSemantic proximity Read ↗

A case for a non‐transgenic animal model of Alzheimer's diseaseSemantic proximity Read ↗

Alzheimer's disease: Aβ, tau and synaptic dysfunctionSemantic proximity Read ↗

Intraneuronal Aβ accumulation and neurodegeneration: Lessons from transgenic modelsSemantic proximity Read ↗

Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations: potential factors in amyloid plaque formation.Semantic proximity Read ↗

A transgenic rat that develops Alzheimer's disease-like amyloid pathology, deficits in synaptic plasticity and cognitive impairment.Semantic proximity Read ↗

Impaired neurogenesis is an early event in the etiology of familial Alzheimer's disease in transgenic mice.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.